An interferon-and ribavirin-free 12-week regimen of once-daily VX-135 and daclatasvir in treatment-naive patients with genotype 1 HCV infection

Authors
Category Primary study
JournalJournal of Hepatology
Year 2014
This article has no abstract
Epistemonikos ID: f1ed0e73aae5b6b6c6bde55065eff8621199de19
First added on: Feb 06, 2025